Xeris Pharmaceuticals, Inc. Announces Dosing of First Patient in Phase 2

Xeris Pharmaceuticals, Inc. Announces Dosing of First Patient in Phase 2
Austin, Texas, April 24, 2014 (GLOBE NEWSWIRE) — Xeris Pharmaceuticals, Inc. ("Xeris"), a clinical stage, specialty biopharmaceutical company developing novel, non-aqueous formulations of injectable drugs, announced today the dosing of the first …
Read more on GlobeNewswire (press release)


MD Anderson Leverages IBM Watson in Cancer-Fighting Efforts
Mike Rhodin, senior vice president for IBM's Watson Group, was in Austin Wednesday meeting with staff in the group's emerging technologies and strategies departments. The Texas capital is a key node in Watson, IBM's big artificial intelligence project, …
Read more on Xconomy


Promising Novel Pertussis Therapy Developed by Biotech Forms Synthetic
Promising Novel Pertussis Therapy Developed by Biotech Forms Synthetic Biologics And Intrexon Inc. With UT Austin Researchers. Posted by: Charles … Agency of Canada. As of January 2014, 424 pertussis cases had already been reported in Texas this year …
Read more on BioNews Texas

90 Day Gender Specific Drug and Alcohol Rehab Program: Austin, Texas – Benchmark Recovery Center — Visit Our Website http://www.benchmarkcenter.com/


Find More Drug Treatment Centers Austin Texas Information…